ArticleScientific reports2025
Computational identification of potential antifungal targets against Claviceps purpurea via MD simulation and MM/GBSA.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Exploration of network-based, machine learning, MD simulations, and MM/GBSA approaches revealed luteolin from Gynura procumbens as key inhibitor of MMP9 in NSCLC.Naunyn-Schmiedeberg's archives of pharmacology · 2026Article
- Isolation, Purification, Identification, and In Vitro ACE Inhibitory Activity of Tyrosine-Arginine Dipeptide From Red Millet Huangjiu.Food science & nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ergot alkaloids produced by the fungus Claviceps purpurea pose significant risks to agriculture and human health. This study systematically investigates the pathogenicity of C. purpurea, analyzing five strains for their proteomic profiles, which revealed genetic variability in size and GC content. We identified proteins localized in various cellular compartments, contributing to our understanding of essential cellular processes. A focus on potential drug targets led to the identification of Alpha-N-acetylglucosaminidase, a hydrolase with significant mass and functional relevance, despite not matching a UniProt entry. The 3D structure prediction confirmed its integrity, making it a suitable target for further analysis. Molecular docking identified ligands CID:51,535,944 and CID:145,242,255 with strong binding affinities to Alpha-N-acetylglucosaminidase, highlighting interactions with key residues like TRP138, ARG651. Molecular docking interactions were validated and showed consistency through MD simulation analyses with greater RMSD, RMSF and PL contacts. This research enhances our understanding of C. purpurea, offering insights into its genetic diversity and cellular mechanisms while identifying promising therapeutic targets. The findings contribute to strategies for mitigating the economic and health impacts of C. purpurea infections, paving the way for innovative interventions in sustainable agriculture.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.